Template:KDRG: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[User:Kosar Doraghi|Kosar Doraghi, M.D.]][mailto:k.doraghi@yahoo.com]
=Kosar Doraghi, M.D.=
=Kosar Doraghi, M.D.=


Line 23: Line 25:
#[[Nirogacestat]]
#[[Nirogacestat]]
#[[Nedosiran]]
#[[Nedosiran]]
#[[Ryzneuta]]
#[[Endocarditis overview]]
#[[Sparsentan]]

Revision as of 20:03, 19 April 2024

Kosar Doraghi, M.D.[1]

Kosar Doraghi, M.D.

Current Position

Associate Editor-in-Chief, Beth Israel Deaconess Medical Center by Harvard Medical School, Boston, Massachusetts, USA, WikiDoc Scholar


Pages Authored/Co-authored/Collaborated

  1. NEXOBRID
  2. RELYVRIO
  3. Deucravacitinib
  4. Ublituximab-xiiy
  5. futibatinib
  6. Tapinarof
  7. Spevigo- spesolimab-sbz
  8. Vericiguat
  9. Dasiglucagon
  10. Ponesimod
  11. Lasmiditan
  12. Nirogacestat
  13. Nedosiran
  14. Ryzneuta
  15. Endocarditis overview
  16. Sparsentan